Bergmann C C, Tong L, Cua R V, Sensintaffar J L, Stohlman S A
Department of Neurology, University of Southern California School of Medicine, Los Angeles 90033.
J Immunol. 1994 Jun 15;152(12):5603-12.
CTL responses are governed by intracellular Ag processing, affinity of peptides for MHC class I molecules, and the T cell repertoire. In this report we demonstrate that a class I Dd-restricted 10-mer CTL epitope within the gp160 envelope glycoprotein of HIV-1 strain IIIB (residues 318-327) contains a 9-amino acid peptide (residues 319-327), which efficiently binds to both the Dd and Ld class I molecules in vitro. The potential for broadening the naturally limited CTL response to include presentation on the Ld class I molecules in vivo was examined using a minigene-based vaccine strategy to insure cytosolic expression of "preprocessed" forms of the gp160 epitope. Immunization with recombinant vaccinia viruses (vac) expressing either the gp160 10 mer or 9 mer, both including an initiation methionine (M318-327 and M319-327, respectively), induced predominantly Dd-restricted CTL specific for native gp160. By contrast, recombinant vac expressing eight gp160 amino acids (M320-327) generated predominantly Ld-restricted CTL which are specific for synthetic gp160 peptides but not native gp160. The ability to induce Ld-restricted CTL suggests that the absence of an Ld-restricted response to native gp160 cannot be attributed to a limited T cell repertoire, but to inefficient processing of gp160 for presentation on Ld. The switch in class I restriction, controlled by a single amino acid within one epitope, demonstrates that nonanchor residues have a profound effect on differential MHC restriction and CTL induction. Thus, minigene-based vaccines expressing minimal epitopes may be useful in inducing a more heterogeneous CTL response than previously appreciated.
细胞毒性T淋巴细胞(CTL)反应受细胞内抗原加工、肽段与MHC I类分子的亲和力以及T细胞库的调控。在本报告中,我们证明,HIV-1 IIIB株包膜糖蛋白gp160内一个受I类Dd分子限制的10肽CTL表位(第318 - 327位氨基酸残基)包含一个9氨基酸肽段(第319 - 327位氨基酸残基),该肽段在体外能有效结合Dd和Ld这两种I类分子。我们采用基于小基因的疫苗策略来确保gp160表位“预处理”形式的胞质表达,以此研究在体内扩大天然有限的CTL反应以包括Ld I类分子提呈的可能性。用表达gp160 10肽或9肽(均包含起始甲硫氨酸,分别为M318 - 327和M319 - 327)的重组痘苗病毒进行免疫,主要诱导出对天然gp160特异的、受Dd限制的CTL。相比之下,表达8个gp160氨基酸(M320 - 327)的重组痘苗病毒主要产生受Ld限制的CTL,这些CTL对合成的gp160肽段特异,但对天然gp160不特异。诱导出受Ld限制的CTL的能力表明,对天然gp160缺乏受Ld限制的反应不能归因于T细胞库有限,而是由于gp160加工成可供Ld提呈的形式效率低下。由一个表位内的单个氨基酸控制的I类限制的转换表明,非锚定残基对不同的MHC限制和CTL诱导有深远影响。因此,表达最小表位的基于小基因的疫苗可能比以前认为的更有助于诱导更具异质性的CTL反应。